Company: MYGN
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0000899923-25-000112
Chunk: 82

Company: MYRIAD GENETICS INC
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 8
Chunk 82
---
 and outstanding at September 30, 20257.5 $12.11 

16

Employee Stock Purchase PlanThe Company also has an Employee Stock Purchase Plan that was initially approved by stockholders in 2012 and was amended and approved by the Board of Directors on September 23, 2021 and the stockholders of the Company on June 2, 2022 (the "Amended and Restated 2012 Purchase Plan"), under which 4.0 million shares of common stock were authorized for issuance. Shares are issued under the Amended and Restated 2012 Purchase Plan twice yearly at the end of each offering period and the number of shares that may be purchased by any participant during an offering period is limited to 5,000 shares. The first offering period of 2025 started on December 1, 2024 and ended on May 31, 2025. The second offering period of 2025 began on June 1, 2025 and will end on November 30, 2025. As of September 30, 2025, 0.2 million shares of common stock were available for issuance under the Amended and Restated 2012 Purchase Plan. Shares purchased under, and compensation expense associated with, the Amended and Restated 2012 Purchase Plan for the three and nine months ended September 30, 2025 and 2024 are as follows:Three months endedSeptember 30,Nine months endedSeptember 30,(in millions)2025202420252024Shares purchased under the plan— — 0.7 0.2 Plan compensation expense$0.1 $0.5 $0.9 $1.6 Stock-Based Compensation ExpenseStock-based compensation expense recognized and included in the Condensed Consolidated Statements of Operations and Comprehensive Loss was allocated as follows:Three months endedSeptember 30,Nine months endedSeptember 30,(in millions)2025202420252024Cost of revenue$0.3 $0.4 $0.9 $1.2 Research and development expense2.0 1.6 6.1 4.4 Sales and marketing expense2.1 2.4 5.6 6.8 General and administrative expense7.8 8.0 19.8 26.5 Total stock-based compensation expense$12.2 $12.4 $32.